KCI/KMQ致力于临床前一体化CRO服务,促进生物医药的发展

About
contact us

    凯斯艾生物科技(苏州)有限公司
    电话:0512-69998805-8022 /8012
    地址:苏州工业园区金鸡湖大道99号纳米城西北区12幢501室

KCI Biotech (SUZHOU) Inc. (KCI) and Jiangsu KMQ biotech Inc. (KMQ) which is a wholly-owned subsidiary of KCI are preclinical Contract Research Organization (CRO) providing specialty preclinical pharmacology services in cardiovascular diseases.

With a professional integrated R&D team and rich experience in pharmacology and pharmacodynamics, the company has gained a large market share in the preclinical research field with high technical barriers and huge demand. It has cooperated with more than 300+ well-known pharmaceutical R&D companies at home and abroad, and completed 50+ domestic and foreign new drug declaration projects.

The core competency of KCI&KMQ stems from our pioneering work and expertise in developing and running specialized animal disease models to test drug candidates and medical devices for their pharmacological effects and biocompatible.

We also conduct adjacency studies in PK/PD, preliminary toxicology, medical image, translational medicine and pathology.

We have standardized animal facilities and an experienced team of personnel.

作为一个临床前CRO一体化服务的提供者,我们在苏州和南通有两个标准化的动物设施,设施总面积超过9000平方米。凯斯艾位于苏州工业园区金鸡湖畔纳米城内,办公、实验面积1800㎡,同时开展大小鼠实验研究。江苏珂玛麒坐落于南通海门生物科技园,拥有7600㎡的大动物实验基地,可同时开展豚鼠,兔,犬,猪以及非人灵长类动物的实验研究,功能实验室设有MRI,CT,X-线,B-超影像室,动物手术室和其它功能实验室。

The Animal Facility has obtained the American Laboratory Animal Management Accreditation AssociationAAALACprofessional certification and laboratory animal use license issued by Jiangsu Science and Technology Department.